Filing Flows › West Pharmaceutical Services (WST) › Net income
West Pharmaceutical Services (WST) net income by quarter
West Pharmaceutical Services' net income was $214M in Q3 2026 (third quarter 2026), +39% from Q2 2026. Over the last 7 quarters it ranged from $89.8M (Q1 2025) to $214M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $214M | +39% | +53% |
| Q2 2026 | $154M | +11% | +17% |
| Q1 2026 | $139M | +5% | +55% |
| Q4 2025 | $132M | -6% | — |
| Q3 2025 | $140M | +6% | — |
| Q2 2025 | $132M | +47% | — |
| Q1 2025 | $89.8M | — | — |
Q3 2026 at a glance
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
Questions
What is West Pharmaceutical Services' net income?
West Pharmaceutical Services' net income was $214M in Q3 2026 (third quarter 2026), +39% from Q2 2026.
How has West Pharmaceutical Services' net income changed?
Over the last 7 quarters it ranged from $89.8M (Q1 2025) to $214M (Q3 2026).
Q3 2026 results → · How West Pharmaceutical Services makes money →